Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-04-16

Clinical Trial Update: Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating mesenchymal stem cell transplantation as a treatment for lupus nephritis. The current status of the trial is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Organ Transplant Institute, China | Conditions: Lupus Nephritis | Phase 1, Phase 2 | Status: UNKNOWN